SCHEMBL7328006

SCHEMBL7328006

COC1=CCC(CCO)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15671064 0.89 TNKS2 (0.35)
SCHEMBL9709785 0.87 CYP4F2 (0.33)
SCHEMBL11801827 0.83
SCHEMBL2348190 0.78
SCHEMBL1031340 0.77
SCHEMBL1145502 0.72
SCHEMBL12812301 0.68 LTB4R (0.31)
SCHEMBL29978727 0.67
SCHEMBL5768455 0.66 SLC7A5 (0.38)
SCHEMBL17953600 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5470849-A Anticoagulants SMITHKLINE BEECHAM CORP. (US) 1995-11-28 US disclosed
EP-0557406-A4 -G(G)-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS 1993-10-06 EP disclosed
EP-0557406-A1 GAMMA-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-09-01 EP disclosed
WO-1992007568-A1 η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1992-05-14 WO disclosed